Prenatal diagnosis of cystic fibrosis in combination with herpetic infection in parents with uncompensated family history

Authors

DOI:

https://doi.org/10.18370/2309-4117.2018.39.49-54

Keywords:

cystic fibrosis, fetal hyperechoic bowel, intrauterine infection, invasive prenatal diagnosis, digestive enzymes in amniotic fluid

Abstract

Cystic fibrosis (CF) is a chronic genetic disorder that affects the exosecretory glands responsible for the production of mucus and sweat; as well as respiratory, digestive and reproductive systems. The article describes a brief description of this disease, the features of intrauterine manifestations and differential diagnosis with other conditions.

In most cases, prenatal diagnosis of CF is offered to a family that already has children with CF. Regarding the prospective prenatal diagnosis of CF in families without CF history, as well as in couples with established status of heterozygous carrier of mutations in the CFTR gene, it is presented mainly in sporadic cases. In all other cases, prenatal diagnosis of CF is based on ultrasound detection of increased intestinal echogenicity. The hyperechogenic intestine is observed in 50–75% fetuses with CF. The incidence of intrauterine infection in fetuses with the hyperechogenic intestine is varies from 0 to 10%. The spectrum of perinatal infections is more often represented by cytomegalovirus, herpes, syphilis, toxoplasmosis, rubella and parvovirus B19.

The second trimester amniotic fluid contains two main enzymes (alkaline phosphatase and gamma-glutamyltranspeptidase), whose decline of level is a reliable marker for CF. The article presents a clinical case of prenatal diagnosis of CF in combination with intrauterine infection with herpes simplex virus in 20 weeks pregnancy in a fetus with a hyperechoic intestine. When

the amniotic fluid was investigated in a fetus with a normal karyotype are revealed decline of alkaline phosphatase and gamma-glutamyltranspeptidase levels, the mutation delF508 CFTR in the homozygous state and the DNA regions homologous HSV I, II types. Taking into account the unfavorable morbid prognosis, the fetus with CF was eliminated for 22 weeks pregnancy at the family’s request. At autopsy were found the typical manifestations of CF in the female abortus. The molecular gene study of both parents confirmed the heterozygous carrier state. The family received recommendations on the mandatory prenatal diagnosis in subsequent pregnancies.

Author Biographies

Н. П. Веропотвелян, CI “Multiregional Center of Medical Genetics and Prenatal Diagnosis named after P.M. Veropotvelyan DRC”, Kryvyi Rih

PhD, Chief Physician

Ю. С. Погуляй, CI “Multiregional Center of Medical Genetics and Prenatal Diagnosis named after P.M. Veropotvelyan DRC”, Kryvyi Rih

Biologist at the Department of Molecular Genetics of Medical and Genetic Research Laboratory

И. В. Суховицкая, CI “Multiregional Center of Medical Genetics and Prenatal Diagnosis named after P.M. Veropotvelyan DRC”, Kryvyi Rih

Biologist of the Biochemical Department of Medical and Genetic Research Laboratory

О. А. Береза, Cherkassy Regional Center for Family Planning and Human Reproduction CRC

Head of the Center for Prenatal Ultrasound Diagnostics, sonologist, obstetrician gynecologist

А. М. Пелых, CI “Multiregional Center of Medical Genetics and Prenatal Diagnosis named after P.M. Veropotvelyan DRC”, Kryvyi Rih

Pathologist of the children’s pathoanatomical department

References

  1. Scotet, V., Duguépéroux, I., Saliou, P., et al. “Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France.” Orphanet J Rare Dis 7 (2012): 14.
  2. Senatorova, A.S., Chernenko, L.N., Muratov, G.R., et al. “Typical and atypical forms of cystic fibrosis in children.” Children’s doctor 2.31 (2014): 10–8.
  3. Reaves, J., Wallace, G. “Unexplained bruising: weighing the pros and cons of possible causes.” Consultant for Pediatricians 9 (2010): 201–2.
  4. Ferreira, L.M. Cystic Fibrosis Statistics. Available from: [https://cysticfibrosisnewstoday. com/cystic-fibrosis-statistics], last accessed Feb 10, 2018.
  5. Massie, J., Delatycki, M.B. “Cystic fibrosis carrier screening.” Paediatric Respiratory Reviews 14.4 (2013): 270–5.
  6. Southern, K.W., Munck, A., Pollitt, R., et al. “A survey of newborn screening for cystic fibrosis in Europe.” J Cyst Fibros 6 (2007): 57–65.
  7. MacKenzie, T., Gifford, A.H., Sabadosa, K.A., et al. “Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the cystic fibrosis foundation patient registry.” Annals of Internal Medicine 161.4 (2014): 233–41.
  8. Canadian Cystic Fibrosis Foundation. Canadian Cystic Fibrosis Patient Data Registry Report (2007).
  9. Dodge, J.A., Lewis, P.A., Stanton, M., Wilsher, J. “Cystic fibrosis mortality and survival in the UK: 1947–2003.” Eur Respir J 29 (2007): 522–6.
  10. McCallum, T.J., Milunsky, J.M., Cunningham, D.L., et al. “Fertility in men with cystic fibrosis: an update on current surgical practices and outcomes.” Chest 118.4 (2000): 1059–62.
  11. Nutan, M., Shally, A., Pratibha, D. “Association of CFTR gene mutation with bronchial asthma.” Indian J Med Res 135.4 (2012): 469–78.
  12. Dahl, M., Børge, G., Lange, P., Tybjaerg-Hansen, A. “Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion.” Allergy Clin Immunol 107 (2001): 818–23.
  13. Dahl, M., Tybjaerg-Hansen, A., Lange, P., Nordestgaard, B.G. “DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma.” Lancet 351 (1998): 1911–3.
  14. Wang, X., Kim, J., McWilliams, R. “Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation.” Arch Otolaryngol Head Neck Surg 131 (2005): 237–40.
  15. Boue, A., Muller, F., Nezelof, C., et al. “Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis.” Hum Genet 74 (1986): 288–97.
  16. Berlin, B.M., Norton, M.E., Sugarman, E.A., et al. “Cystic fibrosis and chromosome abnormalities associated with echogenic fetal bowel.” Obstet Gynecol 94 (1999): 135–8.
  17. Simon-Bouy, B., Satre, V., Ferec, C.M.C., et al. “Hyperechogenic fetal bowel: a large French collaborative study of 682 cases.” Am J Med Genet 121A (2003): 209–13.
  18. Muller, F., Dommergues, M., Simon-Buoy, B., et al. “Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case.” J Med Genet 35 (1998): 657–60.
  19. Lince, D.M., Pretorius, D.H., Manco-Johnson, D., Clewell, W.H. “The clinical significance of increased echogenicity in the fetal abdomen.” Am J Roentgenol 145 (1985): 683–6.
  20. Medvedev, M.V. Prenatal echography. Differential diagnosis and prognosis. 2nd ed. rew. Moscow. Real Time (2009): 384 p.
  21. Slotnick, R.N., Abuhamad, A.Z. “Prognostic implications of fetal echogenic bowel.” Lancet 347 (1996): 85–7.
  22. Oronzo, M. “Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome?” J Prenat Med 5.1 (2011): 9–13.
  23. Bromley, B., Doubilet, P., Frigoletto, F.D., et al. “Is fetal hyperechogenic bowel on fetal sonogram an indication for amniocentesis?” Obstet Gynecol 83 (1994): 647–51.
  24. Sepulveda, W., Reid, R., Nicolaidis, P., et al. “Second-trimester echogenic bowel and intraamniotic bleeding: association between fetal bowel echogenicity and amniotic fluid spectrophotometry at 410 nm.” Am J Obstet Gynecol 174 (1996): 839–42.
  25. Yaron, Y., Hassan, S., Geva, E., et al. “Evaluation of fetal echogenic bowel in the second trimester.” Fetal Diagn Ther 14 (1999): 176–80.
  26. Ghose, I., Mason, G.C., Martinez, D., et al. “Hyperechogenic fetal bowel: a prospective analysis of sixty consecutive cases.” Br J Obstet Gynaecol 107 (2000): 426–29.
  27. Blott, M., Greenough, A., Gamsu, H.R., et al. “Antenatal factors associated with obstruction of the gastrointestinal tract by meconium.” BMJ 296.6617 (1988): 250.
  28. Skoll, A.M., Marquette, G.P., Hamilton, E.F. “Prenatal ultrasonic diagnosis of multiple bowel atresias.” Am J Obstet Gynecol 156 (1987): 472–3.
  29. Muller, F., Dommergues, M., Aubry, M.C., et al. “Hyperechogenic fetal bowel: an Ultrasonographic marker for adverse fetal and neonatal outcome.” Am J Obstet Gynecol 173 (1995): 508–13.
  30. Dechelotte, P.J., Mulliez, N.M., Bouvier, R.J., et al. “Pseudo-meconium ileus due to cy-tomegalovirus infection: a report of three cases.” Pediatr Pathol 12 (1992): 73–82.
  31. Forouzan, I. “Fetal abdominal echogenic mass: an early sign of intrauterine cytomegalovirus infection.” Obstet Gynecol 80 (1992): 535–7.
  32. Sepulveda, W., Sebire, N.J. “Fetal echogenic bowel: a complex scenario.” Ultrasound Obstet Gynecol 16 (2000): 510–4.
  33. Cystic fibrosis. Causes, symptoms, diagnosis and effective treatment. Available from: [http://www.polismed.com/articles-mukoviscidoz-01.html], last accessed Feb 10, 2018.
  34. Brock, D.J. “Amniotic fluid alkaline phosphatase isoenzymes in early prenatal diagnosis of cystic fibrosis.” Lancet 22.2.8356 (1983): 941–3.
  35. Brock, D.J., Bedgood, D., Hayward, C. “Cite as Prenatal diagnosis of cystic fibrosis by assay of amniotic fluid microvillar enzymes.” Human Genetics 65.3 (1984): 248–51.
  36. Veropotvelyan, N.P., Bondarenko, A.A., Myshpylkina, I.V., Kodunov, L.A. “Normative values of excretion of total alkaline phosphatase and gamma-glutamyltranspeptidase in the amniotic fluid in euploid fetuses in the II trimester of pregnancy.” Collection of scientific works of the Association of obstetricians-gynecologists of Ukraine 2.36 (2015): 23.
  37. Veropotvelyan, M.P., Kodunov, L.O., Bondarenko, A.O., et al. “Indicators of digestive enzymes excretion in amniotic fluid in fetuses with common chromosomal trisomyas.” Materials of the IV Congress of Medical Geneticists of Ukraine with international participation (Lviv, Oct 9–11, 2008): 24–5.
  38. Veropotvelyan, N.P., Kodunov, L.A., Mazurak, E.E., et al. “Level of excretion of total alkaline phosphatase and gammaglutyltransferase in amniotic fluid in fruits with chromosomal aneuploidy and normal karyotype.” Materials of the international conference “Fetus as a part of the family” (June 6–8, 2009): 131–2.
  39. Scotet, V., De Braekeleer, M., Audruzet, M.-P. “Prenatal detection of cystic fibrosis by ultrasonography: a retrospective study of more than 346 000 pregnancies.” J Med Genet 39 (2002):443–8.
  40. Guleyuk, N.L., Zastavna, D.V., Hnateyko, O.Z., Bezkorovaina, G.M. Methods of cultivation of amniocytes: methodical recommendations. Kyiv (2005): 18 p.

Downloads

Published

2018-02-28

How to Cite

Веропотвелян, Н. П., Погуляй, Ю. С., Суховицкая, И. В., Береза, О. А., & Пелых, А. М. (2018). Prenatal diagnosis of cystic fibrosis in combination with herpetic infection in parents with uncompensated family history. REPRODUCTIVE ENDOCRINOLOGY, (39), 49–54. https://doi.org/10.18370/2309-4117.2018.39.49-54

Issue

No. 39 (2018)

Section

Interdisciplinary problems

License

Copyright (c) 2018 Н. П. Веропотвелян, Ю. С. Погуляй, И. В. Суховицкая, О. А. Береза, А. М. Пелых

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.